Intravenous ITCZ was given to the patients in both study arms with a loading dose of @ mg/day for @ days followed by @ mg/day until day +@ or when the white blood cell count was > @ @ ( @ ) / L , and then switched to oral ITCZ solution ; prophylaxis was continued until day +@ post transplantation in the short-term arm or until day +@ in the long-term arm .